EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 21 / No 2 (Février 2005) Med Sci (Paris), 21 2 (2005) 141-149 References
Free Access
Issue
Med Sci (Paris)
Volume 21, Number 2, Février 2005
Page(s) 141 - 149
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005212141
Published online 15 February 2005
  1. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway : destruction for the sake of construction. Physiol Rev 2002; 82 : 373–428. [Google Scholar]
  2. Forster A, Hill CP. Proteasome degradation : enter the substrate. Trends Cell Biol 2003; 13 : 550–3. [Google Scholar]
  3. Orlowski M, Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 2003; 415 : 1–5. [Google Scholar]
  4. Verma R, Deshaies RJ. A proteasome howdunit : the case of the missing signal. Cell 2000; 101 : 341–4. [Google Scholar]
  5. Asher G, Lotem J, Sachs L, et al. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA 2002; 99 : 13125–30. [Google Scholar]
  6. Ferrara P, Acquaviva C, Bossis G, et al. Protéolyse intracellulaire et tumorigenèse. Med Sci (Paris) 2001; 17 : 5–13. [Google Scholar]
  7. Coux O, Piechaczyk M. Le système ubiquitine/protéasome : un ensemble (de) complexe(s) pour dégrader les protéines. Med Sci (Paris) 2000; 16 : 623–9. [Google Scholar]
  8. Coux O. The 26S proteasome. Prog Mol Subcell Biol 2002; 29 : 85–107. [Google Scholar]
  9. Sun L, Chen ZJ. The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 2004; 16 : 119–26. [Google Scholar]
  10. Pickart CM. Ubiquitin enters the new millennium. Mol Cell 2001; 8 : 499–504. [Google Scholar]
  11. Weissman AM. Themes and variations on ubiquitynation. Nat Rev Mol Cell Biol 2001; 2 : 169–78. [Google Scholar]
  12. Buchberger A. From UBA to UBX : new words in the ubiquitin vocabulary. Trends Cell Biol 2002; 12 : 216–21. [Google Scholar]
  13. Farras R, Bossis G, Andermarcher E, et al. Mechanisms of delivery of ubiquitinylated proteins to the proteasome : new targets for anti-cancer therapy. Crit Rev Oncol Hematol 2005 (sous presse). [Google Scholar]
  14. Hartmann-Petersen R, Seeger M, Gordon C. Transferring substrates to the 26S proteasome. Trends Biochem Sci 2003; 28 : 26–31. [Google Scholar]
  15. Deveraux Q, Ustrell V, Pickart C, Rechsteiner M. A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem 1994; 269 : 7059–61. [Google Scholar]
  16. Lam YA, Lawson TG, Velayutham M, et al. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 2002; 416 : 763–7. [Google Scholar]
  17. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. Recognition of the polyubiquitin proteolytic signal. EMBO J 2000; 19 : 94–102. [Google Scholar]
  18. Yao T, Cohen RE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 2002; 419 : 403–7. [Google Scholar]
  19. Verma R, Aravind L, Oania R, et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002; 298 : 611–5. [Google Scholar]
  20. Kleijnen MF, Shih AH, Zhou P, et al. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol Cell 2000; 6 : 409–19. [Google Scholar]
  21. Kleijnen MF, Alarcon RM, Howley PM. The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol Biol Cell 2003; 14 : 3868–75. [Google Scholar]
  22. Sakata E, Yamaguchi Y, Kurimoto E, et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep 2003; 4 : 301–6. [Google Scholar]
  23. Verma R, Chen S, Feldman R, et al. Proteasomal proteomics : identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol Biol Cell 2000; 11 : 3425–39. [Google Scholar]
  24. Leggett DS, Hanna J, Borodovsky A, et al. Multiple associated proteins regulate proteasome structure and function. Mol Cell 2002; 10 : 495–507. [Google Scholar]
  25. McClellan AJ, Frydman J. Molecular chaperones and the art of recognizing a lost cause. Nat Cell Biol 2001; 3 : E51–3. [Google Scholar]
  26. Sheaff RJ, Singer JD, Swanger J et al. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 2000; 5 : 403–10. [Google Scholar]
  27. Touitou R, Richardson J, Bose S, et al. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 2001; 20 : 2367–75. [Google Scholar]
  28. Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. Endoproteolytic activity of the proteasome. Science 2003; 299 : 408–11. [Google Scholar]
  29. Bloom J, Amador V, Bartolini F, et al. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003; 115 : 71–82. [Google Scholar]
  30. Bornstein G, Bloom J, Sitry-Shevah D, et al. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 2003; 278 : 25752–7. [Google Scholar]
  31. Bendjennat M, Boulaire J, Jascur T, et al. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 2003; 114 : 599–610. [Google Scholar]
  32. Bossis G, Ferrara P, Acquaviva C, et al. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol Cell Biol 2003; 23 : 7425–36. [Google Scholar]
  33. Tanahashi N, Murakami Y, Minami Y, et al. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 2000; 275 : 14336–45. [Google Scholar]
  34. Ciechanover A, Schwartz AL. Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 2002; 35 : 3–6. [Google Scholar]
  35. Plemper RK, Hammond AL. Protein degradation in human disease. Prog Mol Subcell Biol 2002; 29 : 61–84. [Google Scholar]
  36. Pagano M, Benmaamar R. When protein destruction runs amok, malignancy is on the loose. Cancer Cell 2003; 4 : 251–6. [Google Scholar]
  37. Sherr CJ. Principles of tumor suppression. Cell 2004; 116 : 235–46. [Google Scholar]
  38. Liu YC. Ubiquitin ligases and the immune response. Annu Rev Immunol 2004; 22 : 81–127. [Google Scholar]
  39. Shackelford J, Pagano JS. Tumor viruses and cell signaling pathways : deubiquitination versus ubiquitination. Mol Cell Biol 2004; 24 : 5089–93. [Google Scholar]
  40. Adams J. The proteasome : a suitable antineoplastic target. Nat Rev Cancer 2004; 4 : 349–60. [Google Scholar]
  41. Jing Y. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia. Leuk Lymphoma 2004; 45 : 639–48. [Google Scholar]
  42. Zhang H, Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 2004; 82 : 488–99. [Google Scholar]
  43. Kamal A, Boehm MF, Burrows FJ. Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 2004; 10 : 283–90. [Google Scholar]
  44. Zhang M, Pickart CM, Coffino P. Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. EMBO J 2003; 22 : 1488–96. [Google Scholar]
  45. Krappmann D, Wulczyn FG, Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J 1996; 15 : 6716–26. [Google Scholar]
  46. Forsthoelfel AM, Pena MMO, Xing YY, et al. Structural determinants of the intracellular degradation of human thymidylate synthase. Biochemistry 2004; 43 : 1972–9. [Google Scholar]
  47. Miller CL, Pintel DJ. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation. Virology 2001; 285 : 346–55. [Google Scholar]
  48. Kalejta RF, Shenk T. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci USA 2003; 100 : 3263–8. [Google Scholar]
  49. Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003; 278 : 311–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.